GNH USA

Europe — EMA

Moxonidine Eg

GNH USA supplies Moxonidine Eg (Moxonidine), an imidazoline receptor agonist indicated for essential hypertension. Request a quote for reliable global supply.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidine Eg, is a imidazoline receptor agonist presented as a unknown/unknown for oral use. It treats essential hypertension in adults by lowering blood pressure through reduced sympathetic activity.

GNH USA supplies Moxonidine Eg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is used to manage blood pressure within the essential hypertension therapeutic area.

Essential hypertension: lowers systolic and diastolic pressure in patients with primary high blood pressure.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth - Fatigue - Dizziness - Headache - Nausea - Constipation

Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Allergic reactions (rash, angioedema) - Elevated liver enzymes - Cardiac arrhythmias

What precautions apply to Moxonidine?

Before initiating therapy with Moxonidine, certain safety considerations should be observed.

Monitor blood pressure: check regularly during treatment. Assess renal function: adjust dose if renal impairment is present. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Caution in elderly: increased sensitivity to hypotensive effects. Store at ambient temperature: keep in the original container, protect from moisture.

What does Moxonidine interact with?

Moxonidine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Combined with other antihypertensives: risk of excessive hypotension. - Concomitant use with clonidine: additive central effects may cause severe blood pressure drop.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt the antihypertensive response. - Diuretics: can enhance the hypotensive effect. - Beta‑blockers: monitor for bradycardia and excessive blood pressure reduction.

Frequently asked questions

What is Moxonidine Eg used for?+
Moxonidine Eg is prescribed to lower elevated blood pressure in adults with essential hypertension. By reducing sympathetic nervous system activity, it helps achieve target blood pressure levels and reduces the risk of cardiovascular complications associated with uncontrolled hypertension.
How does Moxonidine work?+
Moxonidine acts as a selective agonist at imidazoline I1 receptors in the brainstem. Stimulation of these receptors diminishes sympathetic outflow, leading to decreased peripheral vascular resistance and lower cardiac output, which together result in reduced arterial blood pressure.
What is the usual dose of Moxonidine Eg?+
The dosage of Moxonidine Eg is individualized by the prescribing clinician based on the patient’s blood pressure response, renal function, and overall health status. The prescriber determines the appropriate strength and dosing schedule for each patient.
Is Moxonidine safe during pregnancy or breastfeeding?+
The safety of Moxonidine in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Moxonidine Eg from GNH USA?+
To request Moxonidine Eg, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Moxonidine compare with other antihypertensive classes?+
Moxonidine belongs to the imidazoline receptor agonist class, which lowers blood pressure by reducing central sympathetic tone. Unlike ACE inhibitors or calcium‑channel blockers, it does not directly affect the renin‑angiotensin system or calcium channels, offering an alternative mechanism that may be useful when other agents are insufficient or not tolerated.
What are the storage requirements for Moxonidine Eg?+
Moxonidine Eg should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.
How is Moxonidine Eg administered?+
Moxonidine Eg is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. The patient should swallow the dosage form whole and follow the dosing schedule provided by the healthcare professional.
What are the most serious risks associated with Moxonidine Eg?+
Serious risks include severe hypotension, bradycardia, allergic reactions such as rash or angioedema, and rare occurrences of liver enzyme elevation or cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like fainting, rapid heartbeat, or signs of an allergic reaction.
Who should not use Moxonidine Eg?+
Moxonidine Eg is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled heart failure, or those taking other potent central antihypertensives, as the risk of excessive blood pressure lowering may be heightened.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Eg Labo Laboratoires Eurogenerics
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU